News and media

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 boosters in 2023. These recommendations replace previous ATAGI COVID-19 vaccine booster advice.

A Pharmacist and Practice Manager from across Australia were sentenced last week after fraudulently claiming more than $470,000 in payments under the Medicare Benefits Scheme (MBS) and the Pharmaceutical Benefits Scheme (PBS).

From 6 February 2023 the human papillomavirus (HPV) vaccine schedule will become a single dose schedule. Catch-up under the National Immunisation Program (NIP) will also be extended to all Australians 25 years and under.

The Strengthening Medicare Taskforce Report is now available. It outlines a vision for Australia’s primary care system of the future.

Big data is giving us a whole picture of Australia’s ageing pathways for the first time. Professor Maria Inacio is working with this data from the Registry of Senior Australians. She aims to find the best aged care and health care services for older Australians.

A medical receptionist from south-eastern Queensland has been convicted after fraudulently claiming more than $253,000 in Medicare payments.

The National Dementia Action Plan is open for consultation. Find out about the plan and how to provide feedback.

We are seeking expressions of interest to fill 7 vacancies on the Australian Technical Advisory Group on Immunisation (ATAGI), commencing 1 July 2023. Consider applying if you are a clinical professional, researcher, service delivery expert or consumer expert.

In 2020, 5 Australian research organisations with expertise in infectious diseases and 2 industry partners formed a consortium. Their aim: to produce an Australian antiviral drug for COVID-19. This research is growing Australia’s ability to discover, test, and manufacture antiviral drugs.

From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR).

Read the transcript of Therapeutic Goods Administration Adjunct Professor John Skerritt's interview with Hamish Macdonald on ABC Radio National on 9 January 2023.

If you are considering cosmetic surgery, it is important that you get trustworthy information first. Information and resources are now available to help you make the safer choice.

See details on the pre-departure testing requirement for COVID-19 for people travelling to Australia from China, including Hong Kong and Macau.

The Minister for Health has determined the end of the COVIDSafe data period effective from 16 August 2022. All COVIDSafe app data has now been deleted from the National COVIDSafe Data Store. 

The Australian Government will introduce pre-departure testing for COVID-19 for people travelling to Australia from the People’s Republic of China.

Read the transcript of Chief Medical Officer, Professor Paul Kelly’s interview on ABC News Breakfast on COVID-19.

How can 13YARN help you?

Most people look forward to the holiday season, but others may find it a challenging time for many different reasons. It is not uncommon for people to feel isolated, sad or anxious, so you’re not alone if you find yourself feeling down this Christmas.

A statement from Professor Paul Kelly, Australian Government Chief Medical Officer, outlining the importance of vaccination against measles and polio.

Read the transcript of Therapeutic Goods Administration Adjunct Professor John Skerritt's interview with Ros Childs on ABC News on 20 December 2022.

Researchers can apply for funding under the 2022 Frontier Health and Medical Research grant opportunity from 13 February 2023. Funding is from the Medical Research Future Fund (MRFF).

The Oceania Asia Games 2022 leaves a lasting legacy.

Researchers can apply for funding under the 2022 Clinical Trials Activity grant opportunity. Funding is from the Medical Research Future Fund (MRFF).

Blocked arteries cause heart attacks by reducing oxygen flow to the heart. Called ischemia, this leads to the death of heart cells. These injuries are permanent and can cause the heart to fail. A new drug could prevent this damage.